How the Multiplier Effect is Working on This $3 Crypto
It's called the multiplier effect in crypto. In short, because of a lack of supply, small inflows of cash can create major moves in the overall value of the crypto. And it's particularly strong in one $3 crypto. Crypto analysts are suggesting it could rise to as high as $100 by next year.
Financials
| Curr Year EPS Estimate | 10.86 |
| Next Quarter EPS Estimate | 2.69 |
| Profit Margin | 25.01% |
| Operating Margin | 24.02 |
| Return on Assets | 0.08 |
| Return on Equity | 0.30 |
| Revenue | 90.6B |
| Earnings Per Share | 9.67 |
| Revenue Per Share | 37.65 |
| Gross Profit | 62,000,001,024 |
| Quarterly Revenue Growth | 0.06 |
General
| Name | Johnson & Johnson |
| Ticker | JNJ |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 138,100 |
About Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke. This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Dividend
Johnson & Johnson pays out a dividend of $5.07 per share, with a dividend yield of 2.72%.
JNJ's last dividend payment was made to shareholders on September 9, 2025.
They pay out 84.80% of their earnings out as a dividend.
Recent Dividends
| Sep 9, 2025 | $1.30 |
| Jun 10, 2025 | $1.30 |
| Mar 4, 2025 | $1.24 |
| Dec 10, 2024 | $1.24 |
| Sep 10, 2024 | $1.24 |
| Jun 4, 2024 | $1.24 |
| Mar 5, 2024 | $1.19 |
| Dec 5, 2023 | $1.19 |
Nebius Vs. Palantir: The AI Infrastructure War At 100x Sales
Wall Street's AI mania has sparked a battle between Nebius (NBIS) and Palantir (PLTR) as investors question where the true value of AI lies.
Trump administration cuts nearly $8B in clean energy projects in blue states
WASHINGTON (AP) — The Trump administration is cancelling $7.6 billion in grants that supported hundreds of clean energy projects in 16 states, all of which voted for Democrat Kamala Harris in last year's presidential election.
New Biotech Offering Targets $426B Rare Disease Market - Ad
The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.
IBM Stock Jumps 5% After Quantum Computing Breakthrough
Shares of International Business Machines Corporation (NASDAQ: IBM) are up Thursday after the company announced it reached a technological milestone in quantum computin
Cathie Wood Dumps $5.2 Million Worth of This AI Stock, Here's What Ark Bought Instead
Ark Invest decided to sell shares of Tempus AI (TEM), despite positive news of FDA clearance for its diagnostic device. They also made other key trades.
Elon's $25 Trillion Confession - Ad
Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.
When Bill Gates Questioned Lyft CEO Risher's Move To Jeff Bezos' 'Tiny, Little Internet Bookstore'—'Stupidest Decision' Ever
David Risher, current CEO of Lyft Inc recently shared a bold career move he made in 1996 that earned him a scathing rebuke from Bill Gates.
FAA Faces Furlough Of 11,000 Employees, Airlines Warn Of Delays Amid Shutdown Threat
11,000 FAA employees face potential furloughs due to government funding lapse. ATC and TSA workers would work without pay.
Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad
A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.
Trump files $15 billion defamation lawsuit against The New York Times
NEW YORK (AP) — President Donald Trump filed a $15 billion defamation lawsuit against The New York Times and four of its journalists on Monday, according to court documents.
Jensen Huang Is A 'Good Friend,' Says Intel CEO Lip-Bu Tan Amid News Of Partnership With Nvidia: Next Era Of Computing Coming?
Intel shares surged more than 20% after CEO Lip-Bu Tan announced a landmark partnership with Nvidia's Jensen Huang to co-develop AI chips, a deal that includes a $5 billion Nvidia investment and positions both companies at the center of the next era of computing.
Want To Know the No.1 Crypto and the No.1 Stock? - Ad
The #1 crypto is just $3. Crypto analysts say a cash injection could drive it as high as $100 in the next year. The #1 stock is equally exciting. It's less than $10 but made a HUGE deal recently to work with Nvidia.
Actor Playing Elon Musk In OpenAI Movie Doesn't Want To Meet Tesla CEO: 'Poisoning My Brain By Watching Lots Of Interviews With Him'
An upcoming 2026 film about OpenAI will see an actor play the role of Elon Musk. Here's how the actor is preparing for playing the billionaire.
Cathie Wood's Ark Bets Big On Solana Treasury Play: Makes $162M Investment In Brera Holdings As Stock Explodes 225%
On Thursday, Cathie Wood-led Ark Invest executed significant trades, notably selling shares of Tempus AI Inc (NASDAQ:TEM) and buying shares of Brera Holdings PLC (NASDAQ:BREA),
Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad
This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.
Why was Jimmy Kimmel's late-night show suspended? Here's what we know
NEW YORK (AP) — ABC has pulled off the air, indefinitely — an unprecedented move that followed backlash from affiliated broadcasters and the head of the Federal Communications Commission over the comic's remarks about last week's killing of conservative activist .
Elon Musk Back Atop Billionaires List, Tesla CEO Almost Recovers Lost Wealth Since Joining Hands With Trump
Elon Musk almost recovers wealth lost since aligning with Trump for 2024 election; now richest person thanks to surging Tesla stocks.
[Revealed] Trump's Next AI Executive Orders? - Ad
A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.
Johnson & Johnson's Tecvayli-Darzalex Combo Shows 100% Response In Newly Diagnosed Myeloma Patients
Johnson & Johnson's Tecvayli-Darzalex regimen showed 100% response rates and high MRD negativity in newly diagnosed multiple myeloma patients.
Carney Cuts The Red Tape, Unveils Over $43 Billion In Flagship Projects
PM Mark Carney announces first projects to be reviewed by Canada's new Major Projects Office, aiming to cut red tape and attract investments.
Why This Crypto Skeptic Had a Change of Heart - Ad
He used to make fun of crypto. Now... he says one $3 crypto could rise to $92 by next year.
Apple's iPhone 17 Series Takes Off, Meta's New Smart Glasses And Major Partnerships In AI Space: This Week In AI
This weekend's tech roundup featured Apple's strong iPhone 17 launch in China and India, Meta's new smart glasses, major AI partnerships like Intel-Nvidia and PayPal-Google, and Jim Cramer questioning Huawei's chip breakthrough.
Bitcoin Struggles Around $112,000, But Here's Why The Bull Run Is Not Over Yet
Bitcoin's (CRYPTO: BTC) is languishing around $112,000, but a prominent trader remains adamant about a strong end to the year.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
Crypto Is The Money For AI, Says Economist As Coinbase CEO Teases Stablecoin-Powered Transactions Between Agents
Renowned economist Alex Tabbarok described cryptocurrencies as the “money” for artificial intelligence on Tuesday after Coinbase Global Inc. (NASDAQ:COIN) CEO teased a new feature that enables AI agents to transact using stablecoins.
Fed convenes meeting with a governor newly appointed by Trump and another he wants to oust
WASHINGTON (AP) — After a and the Federal Reserve began a key meeting on interest rate policy Tuesday with both a new Trump administration appointee and an official the White House has targeted for removal.
The "Mar-A-Lago Accord" Is Now Underway - Ad
The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)
Big Tech's energy-hungry data centers could be bumped off grids during power emergencies
HARRISBURG, Pa. (AP) — With the explosive growth of Big Tech's data centers threatening to overload U.S. electricity grids, policymakers are taking a hard look at a tough-love solution: bumping the energy-hungry data centers off grids during power emergencies.
The Fed faces economic uncertainty and political pressure as it decides whether to cut rates
WASHINGTON (AP) — In a sign of how unusual this week's Federal Reserve meeting is, the decision it will make on — usually the main event — is just one of the key unknowns to be resolved when officials gather Tuesday and Wednesday.
How the Multiplier Effect is Working on This $3 Crypto - Ad
It's called the multiplier effect in crypto. In short, because of a lack of supply, small inflows of cash can create major moves in the overall value of the crypto. And it's particularly strong in one $3 crypto. Crypto analysts are suggesting it could rise to as high as $100 by next year.
As controversy swirls around late-night TV, here's what a new poll shows about who still watches
WASHINGTON (AP) — As late-night talk shows undergo major changes and controversy, a new poll finds that while most Americans don't watch them regularly, the ones who do make such programming part of their routine are more likely to be Democrats.
Warner Bros, Oracle, And Micron Technology Are Among The Top 10 Large-Cap Gainers Last Week (Sep. 8 - Sep. 12): Are The Others In Your Portfolio?
Deal buzz, analyst upgrades, and AI momentum drove top weekly gainers—led by Warner Bros., Oracle, and Micron—across large-cap tech and media.
New Biotech Offering Targets $426B Rare Disease Market - Ad
The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.
Appeals court rejects Trump's bid to unseat Federal Reserve governor Lisa Cook ahead of rate vote
WASHINGTON (AP) — An appeals court ruled Monday that can remain a Federal Reserve governor, rebuffing President Donald Trump’s efforts to remove her just ahead of a key vote on interest rates.
Microsoft resolves European Union probe into Teams
LONDON (AP) — European Union regulators have accepted Microsoft's to Teams, resolving a long-running antitrust investigation that targeted the company's messaging and videoconferencing app.
Elon's $25 Trillion Confession - Ad
Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.
Elizabeth Warren Says Measles Can Hit Record Highs, Slams RFK Jr.'s CDC Panel For Delaying Vaccine: 'How Does That Keep Our Kids Safe?'
Sen. Elizabeth Warren (D-Mass.) on Thursday criticized the Centers for Disease Control and Prevention's vaccine advisory panel following its controversial vote to delay the combined measles, mumps, rubella, and varicella or MMRV vaccine for children under 4 years old.
Uber Eats will soon launch US drone delivery in partnership with Flytrex
Uber Eats will soon be making some meal deliveries with drones.
Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad
A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.
Long-wrought WTO agreement aimed at reducing overfishing takes effect
GENEVA (AP) — A World Trade Organization agreement aimed at reducing took effect Monday, requiring countries to reduce subsidies doled out to fishing fleets and aiming to ensure sustainability of wildlife in the world's seas and oceans.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.